How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant
Journal of Thrombosis and Haemostasis · 2025-05 · 23 (5) · 1648-1656
DOI: 10.1016/j.jtha.2025.01.015 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Thrombosis and Haemostasis, 2025-05. Verfasst von Carlos Bravo-Pérez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Hospital Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB)-Pasc…. Hauptthemen laut MEDLINE: Anticoagulants, Antithrombin III, Antithrombin III Deficiency, Mutation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Fundacion Seneca, European Commission, Instituto de Salud Carlos III.
Abstract (Originalsprache)
BACKGROUND: Antithrombin deficiency represents one of the most severe inherited thrombophilias. Albeit a rare disorder, available knowledge suggests that antithrombin deficiency is underestimated due to the limitations of current diagnostic algorithms. The high clinical variability of this patient population may be another cause of underdiagnosis. Heterozygous type I (quantitative) variants are normally associated with a severe thrombophilic phenotype, while heterozygous type II (qualitative) variants are heterogeneous, including heparin-binding site defects, which are mild/moderate and the most prevalent. Antithrombin Budapest 3 (p.Leu131Phe) is the most frequent type II/heparin-binding site deficiency in Europe, particularly in the Roma population, with a remarkable existence of homozygous subjects. OBJECTIVES: To determine the clinical features, diagnostic procedures, and management of patients with severe antithrombin deficiency, leveraging the study of cases homozygous for the antithrombin Budapest 3 variant. METHODS: Patients were selected from 699 subjects with antithrombin deficiency and recruited over 25 years from reference centers in Spain, Belgium, and Hungary. RESULTS: Guided by 2 illustrative cases with homozygous antithrombin Budapest 3, we report the spectrum and clinical management of patients with this disorder. These cases, with very low antithrombin activity (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Hospital Universitario Morales Meseguer, University of Murcia, Instituto Murciano de Investigacion Biosanitaria (IMIB)-Pascual Parrilla, Centro de Investigacion Biomedica en Red de Enfermedades…
- Department of Hematology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel, Brussels, Belgium.
- Johns Hopkins All Children's Institute for Clinical & Translational Research, St Petersburg, Florida, USA; Department of Pediatrics, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
- Jósa András Teaching Hospital, University of Debrecen, Nyíregyháza, Hungary.
- Division of Clinical Laboratory Science, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Förderung
- Fundacion Seneca
- European Commission
- Instituto de Salud Carlos III
- Hungarian Scientific Research Fund
Zitieren
APA
Bravo-Pérez, C., Corral, J., Orlando, C., Ignjatovic, V., Ilonczai, P., & Bereczky, Z. (2025). How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant. Journal of Thrombosis and Haemostasis, 23(5), 1648-1656. https://doi.org/10.1016/j.jtha.2025.01.015
Vancouver
Bravo-Pérez C, Corral J, Orlando C, Ignjatovic V, Ilonczai P, Bereczky Z. How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant. Journal of Thrombosis and Haemostasis. 2025;23(5):1648-1656. doi:10.1016/j.jtha.2025.01.015
BibTeX
@article{BravoPrez2025,
author = {Bravo-Pérez, Carlos and Corral, Javier and Orlando, Christelle and Ignjatovic, Vera and Ilonczai, Péter and Bereczky, Zsuzsanna},
title = {How we treat severe inherited antithrombin deficiency: lessons from cases homozygous for the Budapest 3 variant},
journal = {Journal of Thrombosis and Haemostasis},
year = {2025},
volume = {23},
number = {5},
pages = {1648--1656},
doi = {10.1016/j.jtha.2025.01.015}
}
EUVIMED